Custom Index Systems’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$187K Buy
+744
New +$160K 0.07% 245
2025
Q4
Sell
-943
Closed -$218K 239
2025
Q3
$218K Buy
+943
New +$192K 0.06% 251
2025
Q1
Sell
-1,437
Closed -$255K 274
2024
Q4
$255K Buy
1,437
+7
+0.5% +$1.29K 0.14% 197
2024
Q3
$282K Buy
1,430
+14
+1% +$2.61K 0.15% 197
2024
Q2
$243K Buy
1,416
+42
+3% +$6.96K 0.14% 207
2024
Q1
$250K Sell
1,374
-680
-33% -$117K 0.14% 204
2023
Q4
$318K Buy
+2,054
New +$299K 0.2% 159

Other funds holding ABBV

Custom Index Systems's ABBV Position: Q2 2026 in Review

Custom Index Systems opened a new position in AbbVie (ABBV) in Q2 2026: 744 shares worth $187K. The stake represents 0.07% of the portfolio and ranks #245 among its holdings. This is a return to the name: Custom Index Systems previously reported a position in ABBV as recently as Q3 2025.

Custom Index Systems first reported a position in ABBV in Q4 2023 and has held it in 7 quarters since. The position peaked at $318K in Q4 2023. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Custom Index Systems held 744 shares of AbbVie worth $187K as of Q2 2026.
  • AbbVie was a new Custom Index Systems position in Q2 2026.
  • AbbVie made up 0.07% of Custom Index Systems's portfolio in Q2 2026, its #245 holding.
  • Custom Index Systems first reported a position in AbbVie in Q4 2023 and has held it in 7 quarters since.
  • Custom Index Systems's AbbVie position peaked at $318K in Q4 2023.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Custom Index Systems's 13F filing for Q2 2026, filed 14 Aug 2026.